P16 Mediated Suppression Of Telomerase In Normal And Malignant Human Breast Cells.

Détails

Ressource 1Télécharger: BIB_BF17B87FFFFA.P001.pdf (921.14 [Ko])
Etat: Public
Version: de l'auteur⸱e
ID Serval
serval:BIB_BF17B87FFFFA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
P16 Mediated Suppression Of Telomerase In Normal And Malignant Human Breast Cells.
Périodique
Aging Cell
Auteur⸱e⸱s
Bazarov A.V., van Sluis M., Hines C., Bassett E., Beliveau A., Campeau E., Mukhopadhyay R., Lee W.J., Melodyev S., Zaslavsky Y., Lee L., Rodier F., Chicas A., Lowe S.W., Benhattar J., Ren B., Campisi J., Yaswen P.
ISSN
1474-9726[electronic], 1474-9718[linking]
Statut éditorial
Publié
Date de publication
06/2010
Peer-reviewed
Oui
Pages
14 p.
Langue
anglais
Notes
Publié en ligne
Résumé
Summary The cyclin-dependent kinase inhibitor p16(INK4a) (CDKN2A) is an important tumor-suppressor gene frequently inactivated in human tumors. p16 suppresses the development of cancer by triggering an irreversible arrest of cell proliferation termed cellular senescence. Here, we describe another anti-oncogenic function of p16 in addition to its ability to halt cell cycle progression. We show that transient expression of p16 stably represses the hTERT gene, encoding the catalytic subunit of telomerase, in both normal and malignant breast epithelial cells. Short-term p16 expression increases the amount of histone H3 trimethylated on lysine 27 (H3K27) bound to the hTERT promoter, resulting in transcriptional silencing, likely mediated by polycomb complexes. Our results indicate that transient p16 exposure may prevent malignant progression in dividing cells by irreversible repression of genes, such as hTERT, whose activity is necessary for extensive self-renewal.
Pubmed
Web of science
Création de la notice
16/07/2010 16:30
Dernière modification de la notice
20/08/2019 16:33
Données d'usage